Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,025 total articles
Fulcrum Therapeutics announced positive clinical data from its Phase 1b PIONEER trial of pociredir for sickle cell disease, showing significant fetal hemoglobin induction and improvements in markers of hemolysis, anemia, and potential reduction in vaso-occlusive crises. The company plans to initiate a registration-enabling trial in the second half …
Lakeland Financial Corporation announced record first quarter 2026 net income of $26.5 million, a 32% increase from the prior year quarter, driven by 5% loan growth, strong net interest margin expansion, and 18% higher noninterest income. The bank experienced healthy organic loan growth, improved asset quality, and increased shareholder returns via…
Aeluma, a NASDAQ-listed semiconductor company, has appointed Dr. Willy Rachmady as Vice President of Strategic Partnerships and Ecosystem. With over 20 years at Intel and extensive expertise in advanced semiconductor technologies, Dr. Rachmady will focus on building strategic manufacturing partnerships and accelerating commercialization of Aeluma's…
SCHMID Group N.V. announced preliminary Q1 2026 results with order intake of €13.6 million and revenues of €18.2 million, noting Q1 is traditionally soft. The company reaffirmed its full-year 2026 guidance expecting revenues over €100 million, an Adjusted EBITDA margin above 12%, and order intake around €114 million. Significant financial maneuvers…
Fulcrum Therapeutics appointed Dr. Josh Lehrer, a seasoned physician-scientist with extensive drug development experience in rare diseases, to its Board of Directors. Dr. Lehrer’s background includes leadership roles in developing therapies for sickle cell disease, notably contributing to the approval of Oxbryta. His addition is expected to bolster…
Eton Pharmaceuticals has begun dosing patients in a clinical pilot study for ET-700, an extended-release zinc acetate formulation targeting treatment of Wilson disease. The study aims to evaluate ET-700's efficacy in reducing intestinal copper absorption with a simpler dosing regimen. Positive results expected in late 2026 could lead to a pivotal t…
Amaze Holdings, Inc. (NYSE American: AMZE) announced an LOI to integrate Digital Innovations Holding Group's proprietary IRMA engine into its platform, aiming to create a new monetization layer for creators and fans via paid influencer programs. This integration will introduce the Amaze credit system to reward participation, promote affiliate commi…
Parsons Corporation, a leading national security and infrastructure technology company, has commenced work as lead designer on the State Route 400 Express Lanes Project in Georgia. This $4.6 billion initiative, the largest transportation public-private partnership in the U.S., aims to improve mobility, reduce congestion, and promote economic growth…
Super Hi International Holding Ltd., operator of internationally recognized Haidilao hot pot restaurants, announced its annual general meeting to be held virtually on June 12, 2026. The company has also filed its annual report on Form 20-F for the fiscal year ending December 31, 2025, reflecting its financial performance and operational status.
OwlTing Group, a Nasdaq-listed global fintech company, announced it will release its financial results for the full year ended December 31, 2025 after the U.S. market closes on April 29, 2026. The company will also hold a management conference call on April 30 to discuss these results and recent business developments. OwlTing is recognized as a hig…
EUDA Health Holdings Limited has received a notice from Nasdaq stating it failed to maintain the required minimum market value of listed securities ($35 million) for 32 consecutive business days. The company has 180 days to regain compliance or face potential delisting from the Nasdaq Capital Market.
Relay Therapeutics announced promising clinical data for the combination of Zovegalisib, Atirmociclib, and aromatase inhibitors (AI) as a frontline triplet therapy for PIK3CA-mutated, HR+/HER2- metastatic breast cancer. The combination showed a 44% objective response rate (ORR) in heavily pre-treated patients, with favorable tolerance and manageabl…
Tower Semiconductor and Axiro Semiconductor announced the availability of high-performance radar beamforming integrated circuits (BFICs) built on Tower's Silicon Germanium (SiGe) technology. Fabricated in Tower's U.S. facilities and designed by Axiro, these BFICs are set to enhance performance in critical defense radar and satcom applications, meet…
Allied Gaming & Entertainment Inc. announced that its major shareholder, Primo, has made a non-binding commitment not to sell or transfer any of their shares until December 31, 2026, demonstrating support for the company's strategic direction and long-term growth. The commitment is non-binding and does not guarantee share retention. Allied Gaming i…
KBR's Mission Technology Solutions unit secured a $200 million recompete contract to support the U.S. Department of Transportation's Volpe National Transportation Systems Center. The five-year agreement involves AI-driven engineering services to improve aviation safety, intelligent transportation systems, vehicle navigation, and large truck safety …
onsemi is expanding its partnership with NIO to support the automaker's shift from 400V to 900V electric vehicle architectures. Leveraging onsemi's latest EliteSiC technology, this collaboration aims to improve efficiency, performance, and scalability in NIO's upcoming EV lineup, including flagship models debuting at the 2026 Beijing Auto Show. The…
Hesai Group, a leading global technology company specializing in 3D perception and physical AI solutions, will release its unaudited Q1 2026 financial results on May 19, 2026, before U.S. market open. Management will hold an earnings conference call on the same day to discuss results and business outlook.
AtaiBeckley Inc., a clinical-stage biotech focused on mental health therapies, received the Silver Award in OVID Health's 2026 Patient Participant Index for its collaboration with Psychedelic Participant Advocacy Network (PsyPAN). This partnership emphasizes incorporating patient voices and experiences in psychedelic clinical trials, enhancing the …
FTI Consulting appoints Mike Davies as Senior Managing Director in its Strategic Communications segment, focusing on the Capital Markets practice in the EMEA region. Davies brings over 25 years of investment banking experience, enhancing FTI's advisory capabilities amid complex market conditions and increased investor scrutiny. The appointment unde…
Garrett Motion Inc. announced a collaboration with Chinese company TONFY to integrate Garrett's oil-free centrifugal compressor technology into TONFY's liquid cooling units for battery energy storage systems, aiming to double cooling capacity and improve efficiency and noise levels. The technology is expected to enter mass production in 2027, enhan…
WeRide and Lenovo have expanded their collaboration to accelerate the commercial deployment of Level 4 autonomous vehicles worldwide. Starting in 2026, they aim to jointly deploy 200,000 autonomous vehicles, including Robotaxis, across more than 40 cities in 12 countries over five years. Utilizing Lenovo's high-performance computing platform HPC 3.…
Apollo-managed funds have agreed to acquire Forvia's Interiors Business Group, a leading global supplier of automotive interior systems. The acquisition enhances Apollo's presence in the automotive supply chain with a company possessing a global footprint and strong OEM partnerships, expected to close in the second half of 2026 after regulatory app…
Oruka Therapeutics, a clinical-stage biotech focused on chronic skin diseases, will report Week 16 data from its Phase 2a EVERLAST-A trial of ORKA-001 in moderate-to-severe plaque psoriasis. The company will hold a conference call and webcast to discuss results on April 27, 2026.
ArrowMark Financial Corp., a closed-end fund listed on NASDAQ, announced its estimated net asset value as of March 31, 2026, to be $21.12 per share. The firm focuses on investing in regulatory capital securities of financial institutions aiming to provide current income to shareholders.
FEMSA has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. SEC as well as Mexican regulatory bodies, disclosing its audited financial statements. FEMSA operates multiple retail and beverage businesses across 18 countries and is a major Coca-Cola bottler worldwide.
